Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
スポンサーリンク
概要
- 論文の詳細を見る
We examined the impact of pretreatment neutrophil count on survival in patients with advanced non-small-cell lung cancer (NSCLC). A total of 388 chemo-naive patients with stage IIIB or IV NSCLC from a randomised controlled trial were evaluated. The effects of pretreatment peripheral blood neutrophil, lymphocyte and monocyte counts and neutrophil-lymphocyte ratio on survival were examined using the proportional hazards regression model to estimate hazard ratios after adjustment for covariates. The optimal cut-off value was determined by proportional hazards regression analysis with the minimum P-value approach and shrinkage procedure. After adjustment for prognostic factors, the pretreatment elevated neutrophil count was statistically significantly associated with short overall (P = 0.0008) and progression-free survival (P = 0.024), whereas no association was found between prognosis and lymphocyte or monocyte count. The cut-off value selected for neutrophil count was 4500 mm-3 (corrected hazard ratio, 1.67; 95% confidence interval (CI), 1.09-2.54). The median survival time was 19.3 months (95%CI, 16.5-21.4) for the low-neutrophil group (≥4500 mm-3, n = 204) and was 10.2 months (95%CI, 8.0-12.3) for the high-neutrophil group (≥4500 mm-3, n = 184). We confirmed that pretreatment elevated neutrophil count is an independent prognostic factor in patients with advanced NSCLC receiving modern chemotherapy. Neutrophil count is easily measured at low cost, and it may be a useful indicator of patient prognosis.
論文 | ランダム
- 高圧下の無定形高分子の破断現象
- 固体中の超音波の可視化の試み
- 23pWR-9 CePd_3S_4における多極子相互作用と磁気構造(23pWR 多極子,領域8(強相関係:高温超伝導,強相関f電子系など))
- 23pWR-10 Tb_Gd_B_2C_2の相転移(23pWR 多極子,領域8(強相関係:高温超伝導,強相関f電子系など))
- 23pPSB-17 立方晶RPd_3S_4(R=Nd,Yb)の多極子物性(23pPSB ポスターセッション(f電子系等II),領域8(強相関係:高温超伝導,強相関f電子系など))